Claire Davies - Concepedia

Author

Claire Davies

Also Known As

C Davies, C T M Davies, C. Davies, C. T. M. DAVIES, C. T. M. Davies, C. T. Mervyn Davies, Claire Davies, Claire T Davies, Jennifer Peterson, Laura Coates

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University of Leeds NIHR Leeds Musculoskeletal Biomedical Research Unit University of Alberta University of Liverpool London School of Hygiene & Tropical Medicine

About

Claire Davies is an author at University of Leeds specializing in medicine, health sciences, and kinesiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	344
2	Health Sciences	6	6	138
3	Education	1	1	15
4	Public Health	1	1	15
5	Social Sciences	1	1	47

Claire Davies

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. C. Focan, S. M. Steinberg, M Blichert-Toft, PubMed	1998	2.2K
Effect of Exercise on Protein Turnover in Man Michael J. Rennie, R. H. T. Edwards, S. Krywawych, Clinical Science	1981	309
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA) Gerd R Burmester, Andrea Rubbert‐Roth, Alain Cantagrel, Annals of the Rheumatic Diseases	2015	122
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer Robert E. Coleman, Emma R. Woodward, Janet E. Brown, Breast Cancer Research and Treatment Bone DiseaseZoledronic AcidBreast OncologyOncologyBone Health	2011	118
Abstract S4-5: Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer. The AZURE Trial (BIG 01/04) RE Coleman, HC Thorpe, David Cameron, Cancer Research Breast OncologyCancer ManagementAdjuvant ChemotherapyPharmacotherapyOsteoporosis	2010	59
A water-maze discrimination learning deficit in the rat following lesion of the habenula Everard W. Thornton, Claire Davies Physiology & Behavior Water-maze DiscriminationCognitive ScienceNeuropsychologyBehavioral SciencesNeurobiological Mechanism	1991	47
Physiological Performance and Work Capacity of Sudanese Cane Cutters with Schistosoma Mansoni Infection Kenneth J. Collins, R. J. Brotherhood, Claire Davies, American Journal of Tropical Medicine and Hygiene	1976	43
RELATIONSHIP BETWEEN INCREASES IN PLASMA CORTISOL CONCENTRATION AND RATE OF CORTISOL SECRETION DURING EXERCISE IN MAN G. C. Cashmore, Claire Davies, J. D. Few Journal of Endocrinology Physical ActivityCortisol SecretionKinesiologyExercisePhysical Exercise	1977	38
Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT Sarah Brown, Colin Everett, Kamran Naraghi, Health Technology Assessment	2018	33
The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug Nuria C. Navarro Coy, Sarah Brown, Ailsa Bosworth, BMC Musculoskeletal Disorders	2014	26

Page 1